Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Radiodermatitis × Dimethyl Sulfoxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Radiodermatitis 1 Neoplasms, Squamous Cell 1 Melanoma 1 Immune System Diseases 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Standard of Care 4 Low-Level Light Therapy 4 Petrolatum 3 Norepinephrine 3 sapropterin 2 Curcumin 2 triethanolamine 1 eucerin 1 epigallocatechin gallate 1 dimethicone 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 calcipotriene 1 Zinc Oxide 1 Triamcinolone Acetonide 1 Thioctic Acid 1 Sodium Hypochlorite 1 Sodium Chloride 1 Silver Sulfadiazine 1 Radiotherapy, Conformal 1 Radiotherapy 1 Melatonin 1 Hydrogel, Polyethylene Glycol Dimethacrylate 1 Hydrocortisone 1 Gels 1 Dimethyl Sulfoxide 1 Catechin 1 Biafine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡